Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating three experimental hepatitis C drugs against Telaprevir in treatment-experienced adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Telaprevir (telaprevir)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C Infection | Phase 3 | Status: COMPLETED | Results posted: 2016-02-11